Elli Marinopoulou

Elli Marinopoulou

Auto-generated profile, based on publicly available information

Elli Marinopoulou

School of Medical Sciences 1 Faculty of Biology Medicine and Health Division of Developmental Biology and Medicine Manchester M13 9PT

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2015 in Nature Cell Biology
Verified
Journal Article
Closed access
RTRoshana Thambyrajah
Roshana Thambyrajah
MMMilena Mazan
Milena Mazan
RPRahima Patel
Rahima Patel
VMVictoria Moignard
Victoria Moignard
MSMonika Marta Stefanska
Monika Marta Stefanska
GLGeorges Lacaud
Georges Lacaud

11 September 2014 in Blood
Verified
Journal Article
Closed access
PDF file
MLMichael Lie-A-Ling
Michael Lie-A-Ling
EMElli Marinopoulou
Elli Marinopoulou
YLYaoyong Li
Yaoyong Li
RPRahima Patel
Rahima Patel
MSMonika Marta Stefanska
Monika Marta Stefanska
GLGeorges Lacaud
Georges Lacaud
Key Points: Generated the first comprehensive RUNX1b-specific transcriptome and binding profile in HE. RUNX1b induces a cell adhesion and migration program prior to the downregulation of endothelial genes and the emergence of blood cells.

1 June 2016 in Cell Reports
Verified
Journal Article
Open access
Alexia EliadesAlexia Eliades
Alexia Eliades
SWSarah Wareing
Sarah Wareing
EMElli Marinopoulou
Elli Marinopoulou
MFMuhammad Z.H. Fadlullah
Muhammad Z.H. Fadlullah
RPRahima Patel
Rahima Patel
Valerie KouskoffValerie Kouskoff
Valerie Kouskoff
It is now well-established that hematopoietic stem cells (HSCs) and progenitor cells originate from a specialized subset of endothelium, termed hemogenic endothelium (HE), via an endothelial-to-hematopoietic transition. However, the molecular mechanisms determining which endothelial progenitors possess this hemogenic potential are currently unknown. Here, we investigated the changes in hemogenic potential in endothelial progenitors at the early stages of embryonic development. Using an ETV2::GFP reporter mouse to isolate emerging endothelial progenitors, we observed a dramatic decrease in hemogenic potential between embryonic day (E)7.5 and E8.5. At the molecular level, Runx1 is expressed at much lower levels in E8.5 intra-embryonic progenitors, while Bmi1 expression is increased. Remarkably, the ectopic expression of Runx1 in these progenitors fully restores their hemogenic potential, as does the suppression of BMI1 function. Altogether, our data demonstrate that hemogenic competency in recently specified endothelial progenitors is restrained through the active silencing of Runx1 expression.

4 October 2016 in eLife
Verified
Journal Article
Open access
NPNick E Phillips
Nick E Phillips
CMCerys S Manning
Cerys S Manning
TPTom Pettini
Tom Pettini
VBVeronica Biga
Veronica Biga
EMElli Marinopoulou
Elli Marinopoulou
NPNancy Papalopulu
Nancy Papalopulu
Recent studies suggest that cells make stochastic choices with respect to differentiation or division. However, the molecular mechanism underlying such stochasticity is unknown. We previously proposed that the timing of vertebrate neuronal differentiation is regulated by molecular oscillations of a transcriptional repressor, HES1, tuned by a post-transcriptional repressor, miR-9. Here, we computationally model the effects of intrinsic noise on the Hes1/miR-9 oscillator as a consequence of low molecular numbers of interacting species, determined experimentally. We report that increased stochasticity spreads the timing of differentiation in a population, such that initially equivalent cells differentiate over a period of time. Surprisingly, inherent stochasticity also increases the robustness of the progenitor state and lessens the impact of unequal, random distribution of molecules at cell division on the temporal spread of differentiation at the population level. This advantageous use of biological noise contrasts with the view that noise needs to be counteracted.

1 March 2018 in Development
Verified
Journal Article
Open access
PDF file
MLMichael Lie-A-Ling
Michael Lie-A-Ling
EMElli Marinopoulou
Elli Marinopoulou
ALAndrew J. Lilly
Andrew J. Lilly
MCMairi Challinor
Mairi Challinor
RPRahima Patel
Rahima Patel
GLGeorges Lacaud
Georges Lacaud
During ontogeny, hematopoietic stem and progenitor cells arise from hemogenic endothelium through an endothelial-to-hematopoietic transition that is strictly dependent on the transcription factor RUNX1. Although it is well established that RUNX1 is essential for the onset of hematopoiesis, little is known about the role of RUNX1 dosage specifically in hemogenic endothelium and during the endothelial-to-hematopoietic transition. Here, we used the mouse embryonic stem cell differentiation system to determine if and how RUNX1 dosage affects hemogenic endothelium differentiation. The use of inducible Runx1 expression combined with alterations in the expression of the RUNX1 co-factor CBFβ allowed us to evaluate a wide range of RUNX1 levels. We demonstrate that low RUNX1 levels are sufficient and necessary to initiate an effective endothelial-to-hematopoietic transition. Subsequently, RUNX1 is also required to complete the endothelial-to-hematopoietic transition and to generate functional hematopoietic precursors. In contrast, elevated levels of RUNX1 are able to drive an accelerated endothelial-to-hematopoietic transition, but the resulting cells are unable to generate mature hematopoietic cells. Together, our results suggest that RUNX1 dosage plays a pivotal role in hemogenic endothelium maturation and the establishment of the hematopoietic system.

2 October 2021 in iScience
Verified
Journal Article
Open access
EMElli Marinopoulou
Elli Marinopoulou
VBVeronica Biga
Veronica Biga
NSNitin Sabherwal
Nitin Sabherwal
AMAnzy Miller
Anzy Miller
JDJayni Desai
Jayni Desai
NPNancy Papalopulu
Nancy Papalopulu
Quiescence is a dynamic process of reversible cell cycle arrest. High-level persistent expression of the HES1 transcriptional repressor, which oscillates with an ultradian periodicity in proliferative neural stem cells (NSCs), is thought to mediate quiescence. However, it is not known whether this is due to a change in levels or dynamics. Here, we induce quiescence in embryonic NSCs with BMP4, which does not increase HES1 level, and we find that HES1 continues to oscillate. To assess the role of HES1 dynamics, we express persistent HES1 under a moderate strength promoter, which overrides the endogenous oscillations while maintaining the total HES1 level within physiological range. We find that persistent HES1 does not affect proliferation or entry into quiescence; however, exit from quiescence is impeded. Thus, oscillatory expression of HES1 is specifically required for NSCs to exit quiescence, a finding of potential importance for controlling reactivation of stem cells in tissue regeneration and cancer.